Home Applications 217806 Application 217806
Type NDA
Sponsor ELI LILLY AND CO Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE SOLUTION;SUBCUTANEOUS 2.5MG/0.5ML (2.5MG/0.5ML) Yes Yes 002 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE SOLUTION;SUBCUTANEOUS 5MG/0.5ML (5MG/0.5ML) Yes Yes 003 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE SOLUTION;SUBCUTANEOUS 7.5MG/0.5ML (7.5MG/0.5ML) Yes Yes 004 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/0.5ML (10MG/0.5ML) Yes Yes 005 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE SOLUTION;SUBCUTANEOUS 12.5MG/0.5ML (12.5MG/0.5ML) Yes Yes 006 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE SOLUTION;SUBCUTANEOUS 15MG/0.5ML (15MG/0.5ML) Yes Yes 007 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 2.5MG/0.5ML (2.5MG/0.5ML) Yes Yes 008 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 5MG/0.5ML (5MG/0.5ML) Yes Yes 009 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 7.5MG/0.5ML (7.5MG/0.5ML) Yes Yes 010 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/0.5ML (10MG/0.5ML) Yes Yes 011 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 12.5MG/0.5ML (12.5MG/0.5ML) Yes Yes 012 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 15MG/0.5ML (15MG/0.5ML) Yes Yes 013 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/2.4ML (4.17MG/ML) Yes Yes 014 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 20MG/2.4ML (8.33MG/ML) Yes Yes 015 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 30MG/2.4ML (12.5MG/ML) Yes Yes 016 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 40MG/2.4ML (16.7MG/ML) Yes Yes 017 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 50MG/2.4ML (20.8MG/ML) Yes Yes 018 ZEPBOUND TIRZEPATIDE SOLUTION;SUBCUTANEOUS 60MG/2.4ML (25MG/ML) Yes Yes 019 ZEPBOUND KWIKPEN TIRZEPATIDE SOLUTION;SUBCUTANEOUS 10MG/2.4ML (4.17MG/ML) Yes Yes 020 ZEPBOUND KWIKPEN TIRZEPATIDE SOLUTION;SUBCUTANEOUS 20MG/2.4ML (8.33MG/ML) Yes Yes 021 ZEPBOUND KWIKPEN TIRZEPATIDE SOLUTION;SUBCUTANEOUS 30MG/2.4ML (12.5MG/ML) Yes Yes 022 ZEPBOUND KWIKPEN TIRZEPATIDE SOLUTION;SUBCUTANEOUS 40MG/2.4ML (16.7MG/ML) Yes Yes 023 ZEPBOUND KWIKPEN TIRZEPATIDE SOLUTION;SUBCUTANEOUS 50MG/2.4ML (20.8MG/ML) Yes Yes 024 ZEPBOUND KWIKPEN TIRZEPATIDE SOLUTION;SUBCUTANEOUS 60MG/2.4ML (25MG/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 24 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217806-001 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE 2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 N217806-002 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE 5MG/0.5ML (5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 N217806-003 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE 7.5MG/0.5ML (7.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 N217806-004 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE 10MG/0.5ML (10MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 N217806-005 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE 12.5MG/0.5ML (12.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 N217806-006 ZEPBOUND (AUTOINJECTOR) TIRZEPATIDE 15MG/0.5ML (15MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 N217806-007 ZEPBOUND TIRZEPATIDE 2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 N217806-008 ZEPBOUND TIRZEPATIDE 5MG/0.5ML (5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 N217806-009 ZEPBOUND TIRZEPATIDE 7.5MG/0.5ML (7.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 N217806-010 ZEPBOUND TIRZEPATIDE 10MG/0.5ML (10MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 N217806-011 ZEPBOUND TIRZEPATIDE 12.5MG/0.5ML (12.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 N217806-012 ZEPBOUND TIRZEPATIDE 15MG/0.5ML (15MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 N217806-013 ZEPBOUND TIRZEPATIDE 10MG/2.4ML (4.17MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 N217806-014 ZEPBOUND TIRZEPATIDE 20MG/2.4ML (8.33MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 N217806-015 ZEPBOUND TIRZEPATIDE 30MG/2.4ML (12.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 N217806-016 ZEPBOUND TIRZEPATIDE 40MG/2.4ML (16.7MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 N217806-017 ZEPBOUND TIRZEPATIDE 50MG/2.4ML (20.8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 N217806-018 ZEPBOUND TIRZEPATIDE 60MG/2.4ML (25MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 N217806-019 ZEPBOUND KWIKPEN TIRZEPATIDE 10MG/2.4ML (4.17MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 N217806-020 ZEPBOUND KWIKPEN TIRZEPATIDE 20MG/2.4ML (8.33MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 N217806-021 ZEPBOUND KWIKPEN TIRZEPATIDE 30MG/2.4ML (12.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 N217806-022 ZEPBOUND KWIKPEN TIRZEPATIDE 40MG/2.4ML (16.7MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 N217806-023 ZEPBOUND KWIKPEN TIRZEPATIDE 50MG/2.4ML (20.8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 N217806-024 ZEPBOUND KWIKPEN TIRZEPATIDE 60MG/2.4ML (25MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20
Orange Book patents# Current patent rows page 1 of 5 · 348 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 78 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 246 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N217806-001 ZEPBOUND (AUTOINJECTOR) 2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 ZEPBOUND (AUTOINJECTOR) 5MG/0.5ML (5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 ZEPBOUND (AUTOINJECTOR) 7.5MG/0.5ML (7.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-004 ZEPBOUND (AUTOINJECTOR) 10MG/0.5ML (10MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-005 ZEPBOUND (AUTOINJECTOR) 12.5MG/0.5ML (12.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-006 ZEPBOUND (AUTOINJECTOR) 15MG/0.5ML (15MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-007 ZEPBOUND 2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-008 ZEPBOUND 5MG/0.5ML (5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-009 ZEPBOUND 7.5MG/0.5ML (7.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-010 ZEPBOUND 10MG/0.5ML (10MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-011 ZEPBOUND 12.5MG/0.5ML (12.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-012 ZEPBOUND 15MG/0.5ML (15MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-013 ZEPBOUND 10MG/2.4ML (4.17MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-014 ZEPBOUND 20MG/2.4ML (8.33MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-015 ZEPBOUND 30MG/2.4ML (12.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-016 ZEPBOUND 40MG/2.4ML (16.7MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-017 ZEPBOUND 50MG/2.4ML (20.8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-018 ZEPBOUND 60MG/2.4ML (25MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-019 ZEPBOUND KWIKPEN 10MG/2.4ML (4.17MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-020 ZEPBOUND KWIKPEN 20MG/2.4ML (8.33MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-021 ZEPBOUND KWIKPEN 30MG/2.4ML (12.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-022 ZEPBOUND KWIKPEN 40MG/2.4ML (16.7MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-023 ZEPBOUND KWIKPEN 50MG/2.4ML (20.8MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-024 ZEPBOUND KWIKPEN 60MG/2.4ML (25MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-20 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217806-001 ZEPBOUND (AUTOINJECTOR) 2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-002 ZEPBOUND (AUTOINJECTOR) 5MG/0.5ML (5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-003 ZEPBOUND (AUTOINJECTOR) 7.5MG/0.5ML (7.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-004 ZEPBOUND (AUTOINJECTOR) 10MG/0.5ML (10MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-005 ZEPBOUND (AUTOINJECTOR) 12.5MG/0.5ML (12.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-006 ZEPBOUND (AUTOINJECTOR) 15MG/0.5ML (15MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2023-11-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-007 ZEPBOUND 2.5MG/0.5ML (2.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-008 ZEPBOUND 5MG/0.5ML (5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-009 ZEPBOUND 7.5MG/0.5ML (7.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-010 ZEPBOUND 10MG/0.5ML (10MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-011 ZEPBOUND 12.5MG/0.5ML (12.5MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-012 ZEPBOUND 15MG/0.5ML (15MG/0.5ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-013 ZEPBOUND 10MG/2.4ML (4.17MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-014 ZEPBOUND 20MG/2.4ML (8.33MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-015 ZEPBOUND 30MG/2.4ML (12.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217806-016 ZEPBOUND 40MG/2.4ML (16.7MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2026-01-07 011fe1cb6892…
Observed Orange Book patent history# Patent history page 1 of 37 · 1,452 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N217806-001 9474780 2036-05-13 Drug substance, Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 11357820 2039-06-14 Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 11918623 2039-06-14 U-3855 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12453756 2039-06-14 Drug product 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12629404 2039-06-14 U-4531 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12629404 2039-06-14 U-4532 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12343382 2039-07-22 U-4228 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12343382 2039-07-22 U-4227 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12343382 2039-07-22 U-4409 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12343382 2039-07-22 U-4410 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12453758 2039-07-22 U-4308 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12453758 2039-07-22 U-4311 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12453758 2039-07-22 U-4310 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12453758 2039-07-22 U-4309 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12616740 2039-07-22 U-4497 2026-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12616740 2039-07-22 U-4498 2026-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-001 12616740 2039-07-22 U-4499 2026-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 9474780 2036-05-13 Drug substance, Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 11357820 2039-06-14 Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 11918623 2039-06-14 U-3855 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12453756 2039-06-14 Drug product 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12629404 2039-06-14 U-4531 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12629404 2039-06-14 U-4532 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12343382 2039-07-22 U-4228 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12343382 2039-07-22 U-4227 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12343382 2039-07-22 U-4410 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12343382 2039-07-22 U-4409 2025-07-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12453758 2039-07-22 U-4311 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12453758 2039-07-22 U-4310 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12453758 2039-07-22 U-4309 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12453758 2039-07-22 U-4308 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12616740 2039-07-22 U-4497 2026-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12616740 2039-07-22 U-4498 2026-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-002 12616740 2039-07-22 U-4499 2026-05-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 9474780 2036-05-13 Drug substance, Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 11357820 2039-06-14 Drug product 2023-12-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 11918623 2039-06-14 U-3855 2024-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 12453756 2039-06-14 Drug product 2025-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 12629404 2039-06-14 U-4531 Drug product 2026-06-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217806-003 12629404 2039-06-14 U-4532 Drug product 2026-06-05 caaa826d4ba7…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 15 · 588 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Zepbound TIRZEPATIDE Eli Lilly and Company 487cd7e7-434c-4925-99fa-aa80b1cc776b 2026-04-22 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 217806 application number: NDA217806